Skip to main content
. 2021 Aug 30;10(9):2245. doi: 10.3390/cells10092245

Figure 2.

Figure 2

Immune suppression in the TME. In the TME, soluble factors and extracellular vesicles (EVs) released by cancer cells promote the differentiation into immune suppressive cells, such as Tregs, MDSCs, M2 macrophages and tolerogenic DCs, which in turn, inhibit the anti-tumor immune response mediated by T cells, CTLs and NK cells.